Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality TestingInvivoscribe Marketing2021-02-17T18:10:07-08:00November 17th, 2020|2020 Publications, Featured Publications, Publications| Read more